151 related articles for article (PubMed ID: 12087815)
1. Imiquimod stimulates innate and cell mediated immunity which controls virus infections and tumors.
Miller R
Int J Dermatol; 2002 May; 41 Suppl 1():3-6. PubMed ID: 12087815
[No Abstract] [Full Text] [Related]
2. [Imiquimod: immunologic-response modifier].
Berman B
Ann Dermatol Venereol; 2000; 127(10 Suppl):3S15-3S18. PubMed ID: 11116858
[No Abstract] [Full Text] [Related]
3. Imiquimod 5% cream: a topical immune response modifier.
Marini M
Int J Dermatol; 2002 May; 41 Suppl 1():1-2. PubMed ID: 12087812
[No Abstract] [Full Text] [Related]
4. Imiquimod: mode of action and therapeutic potential.
Chosidow O; Dummer R
Acta Derm Venereol Suppl (Stockh); 2003 Sep; (214):8-11. PubMed ID: 14606276
[No Abstract] [Full Text] [Related]
5. [Mechanisms of imiquimod indirect antiviral activity].
Hober D; Ajram L; Chehadeh W; Lazrek M; Goffard A; Dewilde A; Wattré P
Ann Biol Clin (Paris); 2005; 63(2):155-63. PubMed ID: 15771973
[TBL] [Abstract][Full Text] [Related]
6. Cytokine induction and modifying the immune response to human papilloma virus with imiquimod.
Slade HB
Eur J Dermatol; 1998; 8(7 Suppl):13-6; discussion 20-2. PubMed ID: 10387958
[TBL] [Abstract][Full Text] [Related]
7. Imiquimod: a cytokine inducer.
Dahl MV
J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S205-8. PubMed ID: 12271278
[No Abstract] [Full Text] [Related]
8. Imiqimod in clinical practice.
Trofatter KF
Eur J Dermatol; 1998; 8(7 Suppl):17-9; discussion 20-2. PubMed ID: 10387959
[TBL] [Abstract][Full Text] [Related]
9. Imiquimod; an international update on therapeutic uses in dermatology.
Tyring S; Conant M; Marini M; Van Der Meijden W; Washenik K
Int J Dermatol; 2002 Nov; 41(11):810-6. PubMed ID: 12453012
[TBL] [Abstract][Full Text] [Related]
10. [New perspective in immunotherapy: local imiquimod treatment].
Kemény L; Nagy N
Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
[TBL] [Abstract][Full Text] [Related]
11. Imiquimod in dermatology: an overview.
Hanna E; Abadi R; Abbas O
Int J Dermatol; 2016 Aug; 55(8):831-44. PubMed ID: 27387373
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological and clinical profile of imiquimod (BESELNA CREAM 5%)].
Tsuda T; Imada K; Mizuguchi K
Nihon Yakurigaku Zasshi; 2008 Jul; 132(1):55-63. PubMed ID: 18622104
[No Abstract] [Full Text] [Related]
13. Imiquimod: a new immune response modifier for the treatment of external genital warts and other diseases in dermatology.
Berman B
Int J Dermatol; 2002 May; 41 Suppl 1():7-11. PubMed ID: 12087816
[No Abstract] [Full Text] [Related]
14. [Imiquimod--a substance with a broad working spectrum].
Oster-Schmidt C
J Dtsch Dermatol Ges; 2004 Oct; 2(10):821-2. PubMed ID: 16281584
[No Abstract] [Full Text] [Related]
15. Imiquimod.
Garland SM
Curr Opin Infect Dis; 2003 Apr; 16(2):85-9. PubMed ID: 12734440
[TBL] [Abstract][Full Text] [Related]
16. Imiquimod applied topically: A novel immune response modifier.
Tyring S
Skin Therapy Lett; 2001 Mar; 6(6):1-4. PubMed ID: 11298484
[TBL] [Abstract][Full Text] [Related]
17. Imiquimod: an immune response modifier.
Dahl MV
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 2):S1-5. PubMed ID: 10861100
[No Abstract] [Full Text] [Related]
18. Imiquimod: a potential role in dermatology?
Eedy DJ
Br J Dermatol; 2002 Jul; 147(1):1-6. PubMed ID: 12100177
[No Abstract] [Full Text] [Related]
19. The effectiveness and tolerability of imiquimod suppositories to treat extensive intra-anal high-grade squamous intraepithelial lesions/warts in HIV-infected individuals.
Fuertes I; Bastida C; Lopez-Cabezas C; Rodríguez-Carunchio L; Ordi J; Mallolas J; Cranston RD; Blanco JL
Int J STD AIDS; 2019 Oct; 30(12):1194-1200. PubMed ID: 31558130
[No Abstract] [Full Text] [Related]
20. Immunomodulatory and pharmacologic properties of imiquimod.
Sauder DN
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 2):S6-11. PubMed ID: 10861101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
